Showing 4 Result(s)

Progressive Multifocal Leukoencephalopathy (PML)

Progressive Multifocal Leukoencephalopathy (PML) is a severe, life-threatening condition that poses a particular risk for MS patients using immunosuppressive therapies. Awareness of the risk factors, regular monitoring, and open communication with healthcare providers are essential for MS patients considering or currently using these medications.

Therapies for Multiple Sclerosis

Multiple sclerosis is a complex and challenging condition to manage, but a wide range of therapies offers hope for patients. From disease-modifying drugs like Alemtuzumab and Anti-CD20 therapies to natural approaches such as sun therapy, each treatment targets different aspects of the disease.

Multiple Sclerosis FAQ

It’s important to contact a healthcare professional, such as a neurologist, who can assess the situation, conduct appropriate tests, and determine whether intervention, such as corticosteroid treatment, is necessary.